Please provide your email address to receive an email when new articles are posted on . The approval is based on positive 1-year data from the phase 3 Pavilion study. This is Susvimo’s third ...

Add Yahoo as a preferred source to see more of our stories on Google. Thanks to advancements in early detection and treatment options, it’s possible to live a long and healthy life after being ...

The treatment of diabetic retinopathy (DR) and diabetic macular edema (DME) has evolved significantly since the introduction of first effective treatments 50 years ago. Like with any disease, ...

New research challenges concerns that tirzepatide harms the eyes, finding lower rates of diabetic retinopathy instead.

Recent reports suggest diabetic retinopathy is more common in younger people than previously thought, leading to a call for more frequent screening for this condition and more attention to follow-up ...

Specialists can identify subtle changes in the retina before symptoms appear and apply treatments that can slow or stop vision loss. Ophthalmologists specialize in the diagnosis and treatment of ...

(RTTNews) - Genentech, a member of the Roche Group (RHHBY), announced that the U.S. Food and Drug Administration has approved Susvimo (ranibizumab injection) 100 mg/mL for the treatment of diabetic ...

Thanks to advancements in early detection and treatment options, it's possible to live a long and healthy life after being diagnosed with type 1 or type 2 diabetes. But since the chronic condition can ...